09:31 EST Biodexa Pharmaceuticals (BDRX) PLC-ADR trading halted, volatility trading pause
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDRX:
- Biodexa announces enrollment of first European patients in Phase 3 Serenta trial
- Biodexa Pharmaceuticals activates first European Site for Phase 3 Serenta trial
- Biodexa Pharmaceuticals files to sell 3.38M units
- Biodexa Pharmaceuticals’ Phase 3 Serenta Trial Approved in Europe
- Biodexa announces approval of CTA by EMA of Phase 3 trial in FAP